About GE Healthcare Technologies, Inc. 
GE Healthcare Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 139 Schemes (44.43%)
Foreign Institutions
Held by 407 Foreign Institutions (16.1%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5,007 Million
(Quarterly Results - Jun 2025)
Net Profit:
500 Million
Pharmaceuticals & Biotechnology
USD 35,685 Million (Mid Cap)
14.00
NA
0.00%
0.68
24.38%
3.67






